An exploration of potent antileishmanial agents derived from quinoline–thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses
- 19 November 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (1) , 396-410
Abstract
Neglected tropical diseases (NTDs) encompass a broad spectrum of infectious diseases predominantly found in tropical and subtropical regions. The limitations of current therapies underscore the critical demand for novel antileishmanial agents. In this investigation, we designed, synthesized, and evaluated ten hybrid compounds (5, 8a–e, and 12a–d) integrating a 7-chloroquinoline scaffold with thiadiazole and thiazole moieties, assessing their in vitro efficacy against Leishmania major. These hybrids exhibited potent activity against the promastigote stage, displaying IC50 values between 0.52 and 3.97 μM, outperforming miltefosine (IC50 = 7.83 μM). Additionally, they demonstrated strong inhibition of the intracellular amastigote form, with IC50 values ranging from 0.76 to 5.62 μM, compared to miltefosine's 8.07 μM. Notably, compound 5 emerged as a highly effective antileishmanial agent against both parasitic stages, while maintaining a favorable safety profile. Mechanistic studies revealed that compound 5 acts via an antifolate mechanism, selectively inhibiting key enzymes in the folate pathway: pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS). Molecular docking and 100 ns molecular dynamics (MD) simulations demonstrated that the quinoline core occupies a hydrophobic pocket formed by residues Phe113, Leu188, Leu226, and Leu229, engaging in stable hydrophobic interactions and π–π stacking with Phe113. Furthermore, the quinoline scaffold and hydrazinecarbodithioate moiety formed hydrogen bonds with Tyr194, Gly225, and His241, reinforcing binding stability. Our findings introduce a promising new class of antileishmanial agents that disrupt the folate biosynthesis pathway, offering significant therapeutic potential for combating leishmaniasis.Keywords
This publication has 84 references indexed in Scilit:
- Advances in the Potential of Quinoline‐Derived Metal Complexes as Antimalarial Agents: A ReviewApplied Organometallic Chemistry, 2025
- Antibacterial Activity of Quinoline‐Based Derivatives against Methicillin‐Resistant Staphylococcus aureus and Pseudomonas aeruginosa: Design, Synthesis, DFT and Molecular Dynamic SimulationsChemistry & Biodiversity, 2023
- The potential therapeutic role of PTR1 gene in non‐healing anthroponotic cutaneous leishmaniasis due to Leishmania tropicaJournal of Clinical Laboratory Analysis, 2020
- Identification of dehydroxy isoquine and isotebuquine as promising antileishmanial agentsArchiv der Pharmazie, 2019
- Synthesis and Biological Evaluation of Ferrocenylquinoline as a Potential Antileishmanial AgentChemMedChem, 2015
- Mechanisms of cellular invasion by intracellular parasitesCellular and Molecular Life Sciences, 2013
- CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR dataJournal of Computational Chemistry, 2013
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005